found TERT promoter mutations in 8 of 51 follicular tumours of uncertain malignant potential, and 3 of 8 eventually developed full‐blown malignant FTC, whereas none of the patients with a WT promoter underwent malignant progression.58 The gene discussed is TERT; the disease is thyroid cancer, nonmedullary, 2.